370 related articles for article (PubMed ID: 28818009)
1. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
Gibson SG; Axler RE; Lemmens T
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
[TBL] [Abstract][Full Text] [Related]
2. Understanding public reactions to commercialization of biobanks and use of biobank resources.
Nicol D; Critchley C; McWhirter R; Whitton T
Soc Sci Med; 2016 Aug; 162():79-87. PubMed ID: 27343817
[TBL] [Abstract][Full Text] [Related]
3. Transparency About Governance Contributes to Biobanks' Trustworthiness: Call for Action.
Gille F; Axler R; Blasimme A
Biopreserv Biobank; 2021 Feb; 19(1):83-85. PubMed ID: 33124891
[TBL] [Abstract][Full Text] [Related]
4. "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.
Moodley K; Singh S
BMC Med Ethics; 2016 Oct; 17(1):57. PubMed ID: 27724893
[TBL] [Abstract][Full Text] [Related]
5. Qualitative study on custodianship of human biological material and data stored in biobanks.
Verlinden M; Nys H; Ectors N; Huys I
BMC Med Ethics; 2016 Mar; 17():15. PubMed ID: 26926004
[TBL] [Abstract][Full Text] [Related]
6. Getting a Fair Share: Attitudes and Perceptions of Biobank Stakeholders Concerning the Fairness of Sample Sharing.
Colledge F; Elger B
Bioethics; 2015 Jul; 29(6):424-30. PubMed ID: 25425240
[TBL] [Abstract][Full Text] [Related]
7. The impact of commercialisation and genetic data sharing arrangements on public trust and the intention to participate in biobank research.
Critchley C; Nicol D; Otlowski M
Public Health Genomics; 2015; 18(3):160-72. PubMed ID: 25790760
[TBL] [Abstract][Full Text] [Related]
8. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
Timmons S; Vezyridis P
Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
[TBL] [Abstract][Full Text] [Related]
9. Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.
Mee B; Gaffney E; Glynn SA; Donatello S; Carroll P; Connolly E; Garrigle SM; Boyle T; Flannery D; Sullivan FJ; McCormick P; Griffin M; Muldoon C; Fay J; O'Grady T; Kay E; Eustace J; Burke L; Sheikh AA; Finn S; Flavin R; Giles FJ
Biopreserv Biobank; 2013 Feb; 11(1):3-11. PubMed ID: 24845249
[TBL] [Abstract][Full Text] [Related]
10. Balancing the local and the universal in maintaining ethical access to a genomics biobank.
Heeney C; Kerr SM
BMC Med Ethics; 2017 Dec; 18(1):80. PubMed ID: 29282045
[TBL] [Abstract][Full Text] [Related]
11. Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts.
Kaye J; Briceño Moraia L; Mitchell C; Bell J; Bovenberg JA; Tassé AM; Knoppers BM
Biopreserv Biobank; 2016 Jun; 14(3):201-6. PubMed ID: 27183185
[TBL] [Abstract][Full Text] [Related]
12. Future-proofing biobanks' governance.
Gille F; Vayena E; Blasimme A
Eur J Hum Genet; 2020 Aug; 28(8):989-996. PubMed ID: 32424324
[TBL] [Abstract][Full Text] [Related]
13. Biobanks and the Moral Concerns of Donors: A Democratic Deliberation.
De Vries RG; Ryan KA; Gordon L; Krenz CD; Tomlinson T; Jewell S; Kim SYH
Qual Health Res; 2019 Nov; 29(13):1942-1953. PubMed ID: 30095038
[TBL] [Abstract][Full Text] [Related]
14. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
Fortin S; Pathmasiri S; Grintuch R; Deschênes M
Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
[TBL] [Abstract][Full Text] [Related]
15. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
[TBL] [Abstract][Full Text] [Related]
16. Business Planning for a Campus-Wide Biobank.
Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
[TBL] [Abstract][Full Text] [Related]
17. A proposed approach to informed consent for biobanks in China.
Liu M; Hu Q
Bioethics; 2014 May; 28(4):181-6. PubMed ID: 22762502
[TBL] [Abstract][Full Text] [Related]
18. Commercial biobanks and genetic research: ethical and legal issues.
Anderlik M
Am J Pharmacogenomics; 2003; 3(3):203-15. PubMed ID: 12814328
[TBL] [Abstract][Full Text] [Related]
19. Who's minding the shop? The role of Canadian research ethics boards in the creation and uses of registries and biobanks.
Gibson E; Brazil K; Coughlin MD; Emerson C; Fournier F; Schwartz L; Szala-Meneok KV; Weisbaum KM; Willison DJ
BMC Med Ethics; 2008 Nov; 9():17. PubMed ID: 19014594
[TBL] [Abstract][Full Text] [Related]
20. Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional study.
Langhof H; Kahrass H; Sievers S; Strech D
Eur J Hum Genet; 2017 Feb; 25(3):293-300. PubMed ID: 28000694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
